PLUS THERAPEUTICS, Inc. Common Stock (PSTV) Stock Price, Quote & AI Analysis
Live PSTV stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for PLUS THERAPEUTICS, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for PLUS THERAPEUTICS, Inc. Common Stock (PSTV), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
PLUS THERAPEUTICS, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
PLUS THERAPEUTICS, Inc. Common Stock Overview
Company information
Company Overview
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
PLUS THERAPEUTICS, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...